Literature DB >> 11112413

iNOS expression inhibits hypoxia-inducible factor-1 activity.

J H Yin1, D I Yang, G Ku, C Y Hsu.   

Abstract

Hypoxia-inducible factor-1 (HIF-1) activates genes important in vascular function such as vascular endothelial growth factor (VEGF), erythropoietin (EPO), and inducible nitric oxide synthase (iNOS). iNOS catalyzes the synthesis of nitric oxide (NO), a free radical gas that mediates a number of cellular processes, including regulation of gene expression, vasodilatation, and neurotransmission. Here we demonstrate that iNOS expression inhibits HIF-1 activity under hypoxia in C6 glioma cells transfected with an iNOS gene and a VEGF promoter-driven luciferase gene. HIF-1 induction of VEGF-luciferase activity in C6 cell is also inhibited by sodium nitroprusside (SNP). Furthermore, pretreatment of C6 cells with N-acetyl-l-cysteine (NAC), an antioxidant, nullified the inhibitory effect of iNOS on HIF-1 binding. These results demonstrate that NO generated by iNOS expression inhibits HIF-1 activity in hypoxic C6 cells and suggest a negative feedback loop in the HIF-1 --> iNOS cascade. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112413     DOI: 10.1006/bbrc.2000.3896

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

Review 2.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

3.  Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1alpha in macrophages during aspirin-induced mesenteric inflammation.

Authors:  I Díez; S Calatayud; C Hernández; E Quintana; J E O'Connor; J V Esplugues; M D Barrachina
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

4.  Nitric oxide induces HIF-1α stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing.

Authors:  A Riaño; D Ortiz-Masià; M Velázquez; S Calatayud; J V Esplugues; Maria Dolores Barrachina
Journal:  J Gastroenterol       Date:  2011-02-09       Impact factor: 7.527

5.  Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.

Authors:  Wen-Hong Kan; Jun-Te Hsu; Martin G Schwacha; Mashkoor A Choudhry; Raghavan Raju; Kirby I Bland; Irshad H Chaudry
Journal:  J Appl Physiol (1985)       Date:  2008-07-17

6.  Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways.

Authors:  Jesús Mateo; Marta García-Lecea; Susana Cadenas; Carlos Hernández; Salvador Moncada
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

7.  Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.

Authors:  Ding-I Yang; Shang-Der Chen; Ya-Ting Yang; Tzyh-Chwen Ju; Jin-Ming Xu; Chung Y Hsu
Journal:  Br J Pharmacol       Date:  2004-02-23       Impact factor: 8.739

Review 8.  HIF-1α Metabolic Pathways in Human Cancer.

Authors:  Naseim Elzakra; Yong Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Imbalance of angiogenesis in diabetic complications: the mechanisms.

Authors:  Zoya Tahergorabi; Majid Khazaei
Journal:  Int J Prev Med       Date:  2012-12

10.  Sumoylation of hypoxia-inducible factor-1α ameliorates failure of brain stem cardiovascular regulation in experimental brain death.

Authors:  Julie Y H Chan; Ching-Yi Tsai; Carol H Y Wu; Faith C H Li; Kuang-Yu Dai; Enya Y H Sun; Samuel H H Chan; Alice Y W Chang
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.